US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot (NCT06479577) | Clinical Trial Compass
RecruitingNot Applicable
US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot
Pakistan46 participantsStarted 2024-02-01
Plain-language summary
To compare the effects of therapeutic ultrasound and high intensity laser therapy on neuropathic pain , strength and quality of life in patients with diabetic foot
Who can participate
Age range50 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with type 2 diabetes.
* Diabetic Patients of age 50 to 75 years.
* Diabetic patient of Both genders
* Diagnosed Diabetes Mellitus with at least 7 years of duration
* Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months
* DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath
Exclusion Criteria:
* Pregnant females
* Lower limb Amputated patients
* History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus.
* Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy.
* History of any low back surgeries and lower limb surgeries
* Patient with malignancy. Patient with epilepsy
* Patient with hemophilia
* Patient with pacemaker, metal implants prosthesis and internal fixation screws.
* Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy
* Patient with a history of neurosurgery